{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:25:29Z","timestamp":1792427129776,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T00:00:00Z","timestamp":1713139200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T00:00:00Z","timestamp":1713139200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Resveratrol is a natural polyphenolic compound present in plants and red wine with many potential health benefits. This compound has various anti-inflammatory and anti-tumor properties and can improve cellular mitochondrial activity. This trial was designed to evaluate the effect on the outcome of IVF of Resveratrol supplementation in women\u2009&gt;\u200935\u00a0years with good ovarian reserve (AMH\u2009&gt;\u20091.2\u00a0ng\/ml). Women were randomized to receive or placebo or Resveratrol (150\u00a0mg per day) for three months preceding the ovarian stimulation (OS). All patients were stimulated with a starting dose of recombinant FSH ranging between 150 and 300\u00a0IU according to age and ovarian reserve. GnRH antagonist flexible protocol was adopted for pituitary suppression. Triggering was performed with urinary hCG (10.000\u00a0IU).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The study was conducted between January 2019 and December 2022 with aa total of 37 cases and 33 controls were recruited. No statistically significant differences in the number of oocytes retrieved, biochemical pregnancy, clinical pregnancy and live birth rates were observed between women treated with resveratrol and control group. A statistically significant increase in the follicle output rate (FORT) and follicle-to oocyte index (FOI) was observed in women treated with resveratrol-based nutraceutical (0.92 <jats:italic>versus<\/jats:italic> 0.77 [<jats:italic>p<\/jats:italic>\u2009=\u20090.02], and 0.77 <jats:italic>versus<\/jats:italic> 0.64 [<jats:italic>p<\/jats:italic>\u2009=\u20090.006], respectively).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Preliminary results from this study indicate that pre-treatment with resveratrol may improve ovarian sensitivity to exogenous FSH, which in turn may decrease the risk of hypo-response to OS in advanced reproductive age women.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13048-024-01391-7","type":"journal-article","created":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T12:01:51Z","timestamp":1713182511000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["The impact of resveratrol on the outcome of the in vitro fertilization: an exploratory randomized placebo-controlled trial"],"prefix":"10.1186","volume":"17","author":[{"given":"A.","family":"Conforti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. G.","family":"Iorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Di Girolamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Y.","family":"Rovetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Picarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Cariati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Gentile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"D\u2019Amato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Gliozheni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Fioretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Alviggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,15]]},"reference":[{"key":"1391_CR1","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.1089\/ars.2008.2412","volume":"11","author":"S Pervaiz","year":"2009","unstructured":"Pervaiz S, Holme AL. Resveratrol: its biologic targets and functional activity. Antioxid Redox Signal. 2009;11:2851\u201397.","journal-title":"Antioxid Redox Signal"},{"key":"1391_CR2","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1093\/carcin\/22.8.1111","volume":"22","author":"J Gusman","year":"2001","unstructured":"Gusman J, Malonne H, Atassi G. A reappraisal of the potential chemopreventive and chemotherapeutic properties of resveratrol. Carcinogenesis. 2001;22:1111\u20137.","journal-title":"Carcinogenesis"},{"key":"1391_CR3","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.cell.2012.01.017","volume":"148","author":"SJ Park","year":"2012","unstructured":"Park SJ, Ahmad F, Philp A, Baar K, Williams T, Luo H, et al. Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases. Cell. 2012;148:421\u201333.","journal-title":"Cell"},{"issue":"6","key":"1391_CR4","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.beem.2012.05.003","volume":"26","author":"LD Osellame","year":"2012","unstructured":"Osellame LD, Blacker TS, Duchen MR. Cellular and molecular mechanisms of mitochondrial function. Best Pract Res Clin Endocrinol Metab. 2012;26(6):711\u201323.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"6","key":"1391_CR5","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1093\/humupd\/dmw028","volume":"22","author":"P May-Panloup","year":"2016","unstructured":"May-Panloup P, Boucret L, Chao de la Barca JM, Desquiret-Dumas V, Ferr\u00e9-L\u2019Hotellier V, Morini\u00e8re C, Descamps P, Procaccio V, Reynier P. Ovarian ageing: the role of mitochondria in oocytes and follicles. Hum Reprod Update. 2016;22(6):725\u201343.","journal-title":"Hum Reprod Update"},{"issue":"12","key":"1391_CR6","doi-asserted-by":"publisher","first-page":"630550","DOI":"10.3389\/fendo.2021.630550","volume":"12","author":"SC Esteves","year":"2021","unstructured":"Esteves SC, Yarali H, Vuong LN, Carvalho JF, \u00d6zbek \u0130Y, Polat M, Le HL, Pham TD, Ho TM. Low Prognosis by the POSEIDON Criteria in Women Undergoing Assisted Reproductive Technology: A Multicenter and Multinational Prevalence Study of Over 13,000 Patients. Front Endocrinol (Lausanne). 2021;12(12):630550.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"8","key":"1391_CR7","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.3390\/jcm11082099","volume":"11","author":"S Cesarano","year":"2022","unstructured":"Cesarano S, Pirtea P, Benammar A, De Ziegler D, Poulain M, Revelli A, Benedetto C, Vall\u00e9e A, Ayoubi JM. Are There Ovarian Responsive Indexes That Predict Cumulative Live Birth Rates in Women over 39 Years? J Clin Med. 2022;11(8):2099.","journal-title":"J Clin Med"},{"issue":"5","key":"1391_CR8","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.rbmo.2020.08.003","volume":"41","author":"R Yang","year":"2020","unstructured":"Yang R, Zhang C, Chen L, Wang Y, Li R, Liu P, Qiao J. Cumulative live birth rate of low prognosis patients with POSEIDON stratification: a single-centre data analysis. Reprod Biomed Online. 2020;41(5):834\u201344.","journal-title":"Reprod Biomed Online"},{"issue":"8","key":"1391_CR9","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1093\/humrep\/deab152","volume":"36","author":"SC Esteves","year":"2021","unstructured":"Esteves SC, Yarali H, Vuong LN, Carvalho JF, \u00d6zbek \u0130Y, Polat M, Le HL, Pham TD, Ho TM, Humaidan P, Alviggi C. Cumulative delivery rate per aspiration IVF\/ICSI cycle in POSEIDON patients: a real-world evidence study of 9073 patients. Hum Reprod. 2021;36(8):2157\u201369.","journal-title":"Hum Reprod"},{"issue":"13","key":"1391_CR10","doi-asserted-by":"publisher","first-page":"973544","DOI":"10.3389\/fendo.2022.973544","volume":"3","author":"P Li","year":"2022","unstructured":"Li P, Chen Z. Association of follicle-to-oocyte index and clinical pregnancy in IVF treatment: A retrospective study of 4,323 fresh embryo transfer cycles. Front Endocrinol (Lausanne). 2022;3(13):973544.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"9","key":"1391_CR11","doi-asserted-by":"publisher","first-page":"589","DOI":"10.3389\/fendo.2018.00589","volume":"17","author":"C Alviggi","year":"2018","unstructured":"Alviggi C, Conforti A, Esteves SC, Vallone R, Venturella R, Staiano S, Castaldo E, Andersen CY, De Placido G. Understanding Ovarian Hypo-Response to Exogenous Gonadotropin in Ovarian Stimulation and Its New Proposed Marker-The Follicle-To-Oocyte (FOI) Index. Front Endocrinol (Lausanne). 2018;17(9):589. https:\/\/doi.org\/10.3389\/fendo.2018.00589.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1391_CR12","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1093\/humrep\/deq361","volume":"26","author":"VK Genro","year":"2011","unstructured":"Genro VK, Grynberg M, Scheffer JB, Roux I, Frydman R, Fanchin R. Serum anti-M\u00fcllerian hormone levels are negatively related to Follicular Output RaTe (FORT) in normo-cycling women undergoing controlled ovarian hyperstimulation. Hum Reprod. 2011;26:671\u20137.","journal-title":"Hum Reprod"},{"key":"1391_CR13","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1093\/humrep\/der479","volume":"27","author":"V Gallot","year":"2012","unstructured":"Gallot V, Berwanger da Silva AL, Genro V, Grynberg M, Frydman N, Fanchin R. Antral follicle responsiveness to follicle-stimulating hormone administration assessed by the Follicular Output RaTe (FORT) may predict in vitro fertilization-embryo transfer outcome. Hum Reprod. 2012;27:1066\u201372.","journal-title":"Hum Reprod"},{"issue":"6","key":"1391_CR14","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1007\/s10815-023-02792-1","volume":"40","author":"A Vaiarelli","year":"2023","unstructured":"Vaiarelli A, Zac\u00e0 C, Spadoni V, Cimadomo D, Conforti A, Alviggi C, Palermo R, Bulletti C, De Santis L, Pisaturo V, Vigiliano V, Scaravelli G, Ubaldi FM, Borini A. Clinical and laboratory key performance indicators in IVF: A consensus between the Italian Society of Fertility and Sterility and Reproductive Medicine (SIFES-MR) and the Italian Society of Embryology, Reproduction and Research (SIERR). J Assist Reprod Genet. 2023;40(6):1479\u201394.","journal-title":"J Assist Reprod Genet"},{"key":"1391_CR15","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/1477-7827-9-112","volume":"9","author":"V Biasoni","year":"2011","unstructured":"Biasoni V, Patriarca A, Dalmasso P, Bertagna A, Manieri C, Benedetto C, Revelli A. Ovarian sensitivity index is strongly related to circulating AMH and may be used to predict ovarian response to exogenous gonadotropins in IVF. Reprod Biol Endocrinol. 2011;9:112.","journal-title":"Reprod Biol Endocrinol"},{"issue":"1","key":"1391_CR16","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.2349\/biij.4.1.e5","volume":"4","author":"A Vijayananthan","year":"2008","unstructured":"Vijayananthan A, Nawawi O. The importance of Good Clinical Practice guidelines and its role in clinical trials. Biomed Imaging Interv J. 2008;4(1):e5.","journal-title":"Biomed Imaging Interv J"},{"issue":"12","key":"1391_CR17","doi-asserted-by":"publisher","first-page":"587051","DOI":"10.3389\/fendo.2021.587051","volume":"19","author":"SC Esteves","year":"2021","unstructured":"Esteves SC, Conforti A, Sunkara SK, Carbone L, Picarelli S, Vaiarelli A, Cimadomo D, Rienzi L, Ubaldi FM, Zullo F, Andersen CY, Orvieto R, Humaidan P, Alviggi C. Improving Reporting of Clinical Studies Using the POSEIDON Criteria: POSORT Guidelines. Front Endocrinol (Lausanne). 2021;19(12):587051.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"22","key":"1391_CR18","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1001\/jama.2022.21022","volume":"328","author":"NJ Butcher","year":"2022","unstructured":"Butcher NJ, Monsour A, Mew EJ, Chan AW, Moher D, Mayo-Wilson E, Terwee CB, Chee-A-Tow A, Baba A, Gavin F, Grimshaw JM, Kelly LE, Saeed L, Thabane L, Askie L, Smith M, Farid-Kapadia M, Williamson PR, Szatmari P, Tugwell P, Golub RM, Monga S, Vohra S, Marlin S, Ungar WJ, Offringa M. Guidelines for Reporting Outcomes in Trial Reports: The CONSORT-Outcomes 2022 Extension. JAMA. 2022;328(22):2252\u201364.","journal-title":"JAMA"},{"issue":"1","key":"1391_CR19","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.fertnstert.2020.11.013","volume":"115","author":"JMN Duffy","year":"2021","unstructured":"Duffy JMN, Bhattacharya S, Bhattacharya S, Bofill M, Collura B, Curtis C, Evers JLH, Giudice LC, Farquharson RG, Franik S, Hickey M, Hull ML, Jordan V, Khalaf Y, Legro RS, Lensen S, Mavrelos D, Mol BW, Niederberger C, Ng EHY, Puscasiu L, Repping S, Sarris I, Showell M, Strandell A, Vail A, van Wely M, Vercoe M, Vuong NL, Wang AY, Wang R, Wilkinson J, Youssef MA, Farquhar CM. Core Outcome Measure for Infertility Trials (COMMIT) initiative. Standardizing definitions and reporting guidelines for the infertility core outcome set: an international consensus development study. Fertil Steril. 2021;115(1):201\u201312.","journal-title":"Fertil Steril"},{"issue":"Pt B","key":"1391_CR20","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.bpobgyn.2022.05.003","volume":"85","author":"SC Esteves","year":"2022","unstructured":"Esteves SC, Yarali H, Vuong LN, Conforti A, Humaidan P, Alviggi C. POSEIDON groups and their distinct reproductive outcomes: Effectiveness and cost-effectiveness insights from real-world data research. Best Pract Res Clin Obstet Gynaecol. 2022;85(Pt B):159\u201387.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"1","key":"1391_CR21","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","volume":"81","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","unstructured":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19\u201325.","journal-title":"Fertil Steril"},{"key":"1391_CR22","doi-asserted-by":"crossref","unstructured":"Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertil Steril. 1997 May;67(5):817\u201321.","DOI":"10.1016\/S0015-0282(97)81391-X"},{"key":"1391_CR23","unstructured":"Morshedi, M. 2010 New 2010 WHO Standards (5th Edition) for the Evaluation of Human Semen. WHO Press Geneva"},{"issue":"3","key":"1391_CR24","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.fertnstert.2009.04.040","volume":"94","author":"FJ Broekmans","year":"2010","unstructured":"Broekmans FJ, de Ziegler D, Howles CM, Gougeon A, Trew G, Olivennes F. The antral follicle count: practical recommendations for better standardization. Fertil Steril. 2010;94(3):1044\u201351.","journal-title":"Fertil Steril"},{"key":"1391_CR25","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/uog.18945","volume":"51","author":"MA Coelho Neto","year":"2018","unstructured":"Coelho Neto MA, Ludwin A, Borrell A, Benacerraf B, Dewailly D, da Silva Costa F, Condous G, Alcazar JL, Jokubkiene L, Guerriero S, et al. Counting ovarian antral follicles by ultrasound: a practical guide. Ultrasound Obstet Gynecol. 2018;51:10\u201320.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"12","key":"1391_CR26","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.3390\/nu10121925","volume":"10","author":"R Spogli","year":"2018","unstructured":"Spogli R, Bastianini M, Ragonese F, et al. Solid dispersion of resveratrol supported on Magnesium DiHydroxide (Resv@MDH) microparticles improves oral bioavailability. Nutrients. 2018;10(12):1925.","journal-title":"Nutrients"},{"key":"1391_CR27","doi-asserted-by":"publisher","first-page":"570047","DOI":"10.3389\/fnut.2020.570047","volume":"7","author":"RG Iannitti","year":"2020","unstructured":"Iannitti RG, Floridi A, Lazzarini A, et al. Resveratrol supported on Magnesium DiHydroxide (Resv@MDH) represents an oral formulation of resveratrol with better gastric absorption and bioavailability respect to pure resveratrol. Front Nutr. 2020;7:570047.","journal-title":"Front Nutr"},{"issue":"1","key":"1391_CR28","first-page":"436830","volume":"14","author":"EFSA Nda Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies)","year":"2016","unstructured":"EFSA Nda Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies). Scientific opinion on the safety of synthetic trans-resveratrol as a novel food pursuant to Regulation (EC) No 258\/97. EFSA J. 2016;14(1):436830.","journal-title":"EFSA J"},{"issue":"3","key":"1391_CR29","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ando.2010.02.021","volume":"71","author":"A Gougeon","year":"2010","unstructured":"Gougeon A. Human ovarian follicular development: from activation of resting follicles to preovulatory maturation. Ann Endocrinol (Paris). 2010;71(3):132\u201343.","journal-title":"Ann Endocrinol (Paris)"},{"issue":"1","key":"1391_CR30","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12958-023-01113-6","volume":"21","author":"S Palomba","year":"2023","unstructured":"Palomba S, Costanzi F, Nelson SM, Caserta D, Humaidan P. Interventions to prevent or reduce the incidence and severity of ovarian hyperstimulation syndrome: a systematic umbrella review of the best clinical evidence. Reprod Biol Endocrinol. 2023;21(1):67.","journal-title":"Reprod Biol Endocrinol"},{"issue":"9","key":"1391_CR31","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1093\/humrep\/dex234","volume":"32","author":"F Zegers-Hochschild","year":"2017","unstructured":"Zegers-Hochschild F, Adamson GD, Dyer S, Racowsky C, de Mouzon J, Sokol R, Rienzi L, Sunde A, Schmidt L, Cooke ID, Simpson JL, van der Poel S. The International Glossary on Infertility and Fertility Care, 2017. Hum Reprod. 2017;32(9):1786\u2013801.","journal-title":"Hum Reprod"},{"issue":"4","key":"1391_CR32","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.fertnstert.2020.08.016","volume":"115","author":"F Ragonese","year":"2021","unstructured":"Ragonese F, Monarca L, De Luca A, Mancinelli L, Mariani M, Corbucci C, Gerli S, Iannitti RG, Leonardi L, Fioretti B. Resveratrol depolarizes the membrane potential in human granulosa cells and promotes mitochondrial biogenesis. Fertil Steril. 2021;115(4):1063\u201373.","journal-title":"Fertil Steril"},{"issue":"5","key":"1391_CR33","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.3390\/antiox11051019","volume":"11","author":"R Battaglia","year":"2022","unstructured":"Battaglia R, Caponnetto A, Caringella AM, Cortone A, Ferrara C, Smirni S, Iannitti R, Purrello M, D\u2019Amato G, Fioretti B, Di Pietro C. Resveratrol Treatment Induces Mito-miRNome Modification in Follicular Fluid from Aged Women with a Poor Prognosis for In Vitro Fertilization Cycles. Antioxidants (Basel). 2022;11(5):1019.","journal-title":"Antioxidants (Basel)"},{"issue":"5","key":"1391_CR34","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/j.fertnstert.2022.01.024","volume":"117","author":"G Bildik","year":"2022","unstructured":"Bildik G, Esmaeilian Y, Hela F, Akin N, \u0130ltumur E, Yusufoglu S, Yildiz CS, Yakin K, Oktem O. Cholesterol uptake or trafficking, steroid biosynthesis, and gonadotropin responsiveness are defective in young poor responders. Fertil Steril. 2022;117(5):1069\u201380.","journal-title":"Fertil Steril"},{"key":"1391_CR35","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.envint.2017.11.011","volume":"111","author":"R Machtinger","year":"2018","unstructured":"Machtinger R, Gaskins AJ, Racowsky C, Mansur A, Adir M, Baccarelli AA, Calafat AM, Hauser R. Urinary concentrations of biomarkers of phthalates and phthalate alternatives and IVF outcomes. Environ Int. 2018;111:23\u201331.","journal-title":"Environ Int"},{"issue":"2","key":"1391_CR36","first-page":"370","volume":"31","author":"P Drakopoulos","year":"2016","unstructured":"Drakopoulos P, Blockeel C, Stoop D, Camus M, de Vos M, Tournaye H, Polyzos NP. Conventional ovarian stimulation and single embryo transfer for IVF\/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos? Hum Reprod. 2016;31(2):370\u20136.","journal-title":"Hum Reprod"},{"issue":"4","key":"1391_CR37","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.fertnstert.2018.04.039","volume":"110","author":"NP Polyzos","year":"2018","unstructured":"Polyzos NP, Drakopoulos P, Parra J, Pellicer A, Santos-Ribeiro S, Tournaye H, Bosch E, Garcia-Velasco J. Cumulative live birth rates according to the number of oocytes retrieved after the first ovarian stimulation for in vitro fertilization\/intracytoplasmic sperm injection: a multicenter multinational analysis including \u223c15,000 women. Fertil Steril. 2018;110(4):661-670.e1.","journal-title":"Fertil Steril"},{"issue":"2","key":"1391_CR38","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.rbmo.2019.03.205","volume":"39","author":"A Ochiai","year":"2019","unstructured":"Ochiai A, Kuroda K, Ikemoto Y, Ozaki R, Nakagawa K, Nojiri S, Takeda S, Sugiyama R. Influence of resveratrol supplementation on IVF-embryo transfer cycle outcomes. Reprod Biomed Online. 2019;39(2):205\u201310.","journal-title":"Reprod Biomed Online"},{"issue":"8","key":"1391_CR39","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1007\/s10815-019-01461-6","volume":"36","author":"M Bahramrezaie","year":"2019","unstructured":"Bahramrezaie M, Amidi F, Aleyasin A, Saremi A, Aghahoseini M, Brenjian S, Khodarahmian M, Pooladi A. Effects of resveratrol on VEGF & HIF1 genes expression in granulosa cells in the angiogenesis pathway and laboratory parameters of polycystic ovary syndrome: a triple-blind randomized clinical trial. J Assist Reprod Genet. 2019;36(8):1701\u201312.","journal-title":"J Assist Reprod Genet"},{"issue":"25","key":"1391_CR40","doi-asserted-by":"publisher","first-page":"7640","DOI":"10.1080\/14767058.2021.1958313","volume":"35","author":"S Gerli","year":"2022","unstructured":"Gerli S, Della Morte C, Ceccobelli M, Mariani M, Favilli A, Leonardi L, Lanti A, Iannitti RG, Fioretti B. Biological and clinical effects of a resveratrol-based multivitamin supplement on intracytoplasmic sperm injection cycles: a single-center, randomized controlled trial. J Matern Fetal Neonatal Med. 2022;35(25):7640\u20138.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"1391_CR41","unstructured":"American College of Obstetricians and Gynecologists Committee on Gynecologic Practice and Practice Committee. Female age-related fertility decline. Committee Opinion No. 589. Fertil Steril. 2014 Mar;101(3):633\u20134."},{"issue":"10","key":"1391_CR42","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3389\/fendo.2019.00094","volume":"20","author":"FM Ubaldi","year":"2019","unstructured":"Ubaldi FM, Cimadomo D, Vaiarelli A, Fabozzi G, Venturella R, Maggiulli R, Mazzilli R, Ferrero S, Palagiano A, Rienzi L. Advanced Maternal Age in IVF: Still a Challenge? The Present and the Future of Its Treatment. Front Endocrinol (Lausanne). 2019;20(10):94.","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-024-01391-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-024-01391-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-024-01391-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T12:05:46Z","timestamp":1713182746000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-024-01391-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,15]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1391"],"URL":"https:\/\/doi.org\/10.1186\/s13048-024-01391-7","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,15]]},"assertion":[{"value":"24 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the local Ethics Committee of the University of Naples Federico II on January 2019 (n.328\/18).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"81"}}